Neil Solomons Selected Research

voclosporin

1/2022	Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE.
1/2021	Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
1/2019	A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Solomons Research Topics

Disease

9	Lupus Nephritis 01/2021 - 05/2009
3	Proteinuria 01/2019 - 01/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2013 - 11/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Epilepsy (Aura) 01/2019
1	Body Weight (Weight, Body) 11/2011
1	Pemphigus (Pemphigus Vulgaris) 08/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2010

Drug/Important Bio-Agent (IBA)

9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 05/2009
5	CreatinineIBA 08/2020 - 01/2010
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2013 - 05/2009
3	voclosporinIBA 01/2022 - 01/2019
2	Calcineurin InhibitorsIBA 01/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 08/2010
1	GlucuronidesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2013
1	Azathioprine (Imuran)FDA LinkGeneric 11/2011
1	Prednisone (Sone)FDA LinkGeneric 08/2010
1	Proteins (Proteins, Gene)FDA Link 01/2010

Therapy/Procedure

5	Therapeutics 01/2019 - 05/2009
1	Remission Induction 01/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019
1	Time-to-Treatment 11/2011